Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...

A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer ...

Low baseline ctDNA levels in advanced breast cancer patients predict better response to targeted therapy and longer ...

The study of cancer genomics has revealed that both inherited (germline) and acquired (somatic) genetic variations significantly influence cancer ...

Jan 22 (Reuters) - Corcept Therapeutics said on Thursday a late-stage trial showed its experimental drug in combination with chemotherapy helped reduce the risk of death in patients with a type of ...

Researchers say cancer's ability to evade treatment and recur is partly due to tumor cells switching between states to ...

Knowable Magazine reports on advancements in pancreatic cancer treatment, including new drugs, vaccines, and early diagnostic ...

When lung cancer treatment stops working, what happens next? New research reveals the answer may depend on how the cancer ...

Johns Hopkins University cancer researcher Mikala Egeblad has received the 2025 Ernst W. Bertner Memorial Award in ...

Significantly longer progression-free survival seen among patients with previously untreated, PD-L1 advanced or metastatic ...

Fewer people under age 50 are dying from cancer in the U.S., but colorectal cancer mortality rates continue to surge ...

Prostate cancer begins in the prostate, a small gland located just below the bladder, present only in people assigned male at birth (AMAB). This gland is in charge of producing seminal fluid, and it ...